161 related articles for article (PubMed ID: 19882518)
1. VEGF Trap(R1R2) suppresses experimental corneal angiogenesis.
Oliveira HB; Sakimoto T; Javier JA; Azar DT; Wiegand SJ; Jain S; Chang JH
Eur J Ophthalmol; 2010; 20(1):48-54. PubMed ID: 19882518
[TBL] [Abstract][Full Text] [Related]
2. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
Azar DT
Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of triamcinolone acetonide on corneal neovascularization.
Murata M; Shimizu S; Horiuchi S; Taira M
Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):205-9. PubMed ID: 16044325
[TBL] [Abstract][Full Text] [Related]
4. KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.
Zhou AY; Bai YJ; Zhao M; Yu WZ; Li XX
Ophthalmic Res; 2013; 50(3):180-6. PubMed ID: 24008241
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit.
Wong CG; Rich KA; Liaw LH; Hsu HT; Berns MW
Curr Eye Res; 2001 Feb; 22(2):140-7. PubMed ID: 11402391
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 7A promotes angiogenesis in an experimental corneal neovascularization model.
Ghanem RC; Han KY; Rojas J; Ozturk O; Kim DJ; Jain S; Chang JH; Azar DT
Curr Eye Res; 2011 Nov; 36(11):989-96. PubMed ID: 21999225
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of corneal angiogenesis by local application of vasostatin.
Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1.
Zhou SY; Xie ZL; Xiao O; Yang XR; Heng BC; Sato Y
Mol Vis; 2010 Jul; 16():1389-98. PubMed ID: 20680097
[TBL] [Abstract][Full Text] [Related]
10. Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice.
Kure T; Chang JH; Kato T; Hernández-Quintela E; Ye H; Lu PC; Matrisian LM; Gatinel D; Shapiro S; Gosheh F; Azar DT
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):137-44. PubMed ID: 12506066
[TBL] [Abstract][Full Text] [Related]
11. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
Chen WL; Lin CT; Lin NT; Tu IH; Li JW; Chow LP; Liu KR; Hu FR
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of experimental angiogenesis of cornea by somatostatin.
Wu PC; Liu CC; Chen CH; Kou HK; Shen SC; Lu CY; Chou WY; Sung MT; Yang LC
Graefes Arch Clin Exp Ophthalmol; 2003 Jan; 241(1):63-9. PubMed ID: 12545294
[TBL] [Abstract][Full Text] [Related]
13. A model of angiogenesis in the mouse cornea.
Kenyon BM; Voest EE; Chen CC; Flynn E; Folkman J; D'Amato RJ
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1625-32. PubMed ID: 8675406
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of choroidal and corneal pathologic neovascularization by Plgf1-de gene transfer.
Tarallo V; Bogdanovich S; Hirano Y; Tudisco L; Zentilin L; Giacca M; Ambati J; De Falco S
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):7989-96. PubMed ID: 23139276
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of corneal neovascularization by alpha(v)-integrin antagonists in the rat.
Klotz O; Park JK; Pleyer U; Hartmann C; Baatz H
Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):88-93. PubMed ID: 10664059
[TBL] [Abstract][Full Text] [Related]
16. Localization of angiotensin converting enzyme in rabbit cornea and its role in controlling corneal angiogenesis in vivo.
Sharma A; Bettis DI; Cowden JW; Mohan RR
Mol Vis; 2010 Apr; 16():720-8. PubMed ID: 20431722
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization.
Chen WL; Chen YM; Chu HS; Lin CT; Chow LP; Chen CT; Hu FR
PLoS One; 2014; 9(4):e94205. PubMed ID: 24714670
[TBL] [Abstract][Full Text] [Related]
19. Differential retinal angiogenic response to sustained intravitreal release of VEGF and bFGF in different pigmented rabbit breeds.
Erb MH; Sioulis CE; Kuppermann BD; Osann K; Wong CG
Curr Eye Res; 2002 Apr; 24(4):245-52. PubMed ID: 12324862
[TBL] [Abstract][Full Text] [Related]
20. The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization.
Dell S; Peters S; Müther P; Kociok N; Joussen AM
Invest Ophthalmol Vis Sci; 2006 May; 47(5):1928-37. PubMed ID: 16639000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
